Samuel M. Cohen, MD, PhD
Havlik-Wall Professor of Oncology
Professor, UNMC Department of Pathology, Microbiology and Immunology
Samuel M. Cohen, MD, PhD, is a professor in the UNMC Department of Pathology, Microbiology and Immunology, and is the Havlik-Wall Professor of Oncology.
He received his MD and PhD from the University of Wisconsin, and served a pathology residency in pathology at St. Vincent Hospital in Worcester, Massachusetts. He served on the faculty of the University of Massachusetts Medical School until 1981, when he joined UNMC as professor in Pathology and Microbiology and in UNMC's cancer center. He served as department vice chair from 1981-92, and as chair 1992-2007.
Dr. Cohen is active in surgical pathology, currently with a focus on gastrointestinal pathology. He served on the National Comprehensive Cancer Network panel for lower urinary tract tumors. He has been involved with basic research on chemical carcinogenesis, toxicology, and toxicologic pathology, having maintained an extramurally funded research program for almost 50 years.
Dr. Cohen serves on numerous national and international committees, including on the boards of Scientific Counselors for the National Toxicology Program of the National Institute of Environmental Health Sciences, and the Environmental Protection Agency Science Advisory Board.
He has more than 480 publications in peer reviewed journals and more than 50 chapters.
- MD and PhD: Experimental oncology, University of Wisconsin, 1972.
- Residency: Pathology, St. Vincent Hospital, Worcester, Massachusetts, 1972-75.
- Board certification: Anatomic and Clinical Pathology, 1976.
- Visiting professor: Nagoya City University, Nagoya, Japan, 1976-77.
Chemical carcinogenesis, mode of action and human relevance of animal studies, risk assessment, toxicologic pathology, arsenic.
- Cell proliferation in carcinogenesis.
- Chemical carcinogenicity revisited 3: Risk assessment of carcinogenic potential based on the current state of knowledge of carcinogenesis in humans.
- Dose-response for assessing the cancer risk of inorganic arsenic in drinking water: the scientific basis for use of a threshold approach.
- Fellow, American Association for the Advancement of Science.
- Lehman Award, Merit Award, and Founders Award, Society of Toxicology.
- Lifetime Achievement Award, Society of Toxicologic Pathology.
- Distinguished Science Award, American College of Toxicology.
- Fellow, Academy of Toxicological Sciences.
- Barnes Prize, British Toxicology Society.
- Distinguished Scientist in Cancer Research, Japan Academy and Japanese National Cancer Center.